Outcomes Best for Early Enrollment in Cardiac Rehab

This article originally appeared here.
Share this content:
Outcomes Best for Early Enrollment in Cardiac Rehab
Outcomes Best for Early Enrollment in Cardiac Rehab

(HealthDay News) -- Early enrollment may improve outcomes in cardiac rehabilitation (CR), according to research published in the Dec. 15 issue of The American Journal of Cardiology.

Dominic A. Johnson, M.D., of the Wake Forest School of Medicine in Winston-Salem, N.C., and colleagues analyzed data from 1,241 patients who were consecutively enrolled in CR less than one year after treatment of cardiac events or cardiac surgery. The effects of delayed enrollment in CR on patient outcomes were assessed.

The researchers found that the mean delay time for CR was 34 days. Factors associated with delay times greater than 30 days included older age, female gender, nonwhite race, unemployed status, and increased length of hospital stay before CR after index cardiac event. Although significant improvements in metrics were observed in patients in CR, smaller changes were observed in peak metabolic equivalent levels (METs) and weight in patients with delay times greater than 30 days compared to those with delay times of 0 to 15 days and 16 to 30 days. Delay time to CR greater than 30 days, compared with 0 to 15 days, remained an independent predictor of decreased MET improvement, after multivariable adjustment (P < 0.001).

"Although all patients showed improvements in key metrics regardless of delay time, CR was of greatest benefit, particularly for weight and exercise capacity, when initiated within 15 days of the index event," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »